Association of the metabolic score for insulin resistance with cardiovascular diseases, cardiovascular and all-cause mortality in Chinese hypertensive population
ImportanceLittle is known about the relationship between the metabolic score for insulin resistance (METS-IR) and the prognosis of hypertensive patients in China.ObjectiveTo investigate the association between the novel non–insulin‐based METS-IR index and the cardiovascular composite endpoints and a...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-03-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1326436/full |
| _version_ | 1797269039497609216 |
|---|---|
| author | Liting Zhang Liting Zhang Liting Zhang Liting Zhang Chao Yu Chao Yu Chao Yu Chao Yu Tao Wang Tao Wang Tao Wang Tao Wang Wei Zhou Wei Zhou Wei Zhou Wei Zhou Huihui Bao Huihui Bao Huihui Bao Huihui Bao Xiaoshu Cheng Xiaoshu Cheng Xiaoshu Cheng Xiaoshu Cheng |
| author_facet | Liting Zhang Liting Zhang Liting Zhang Liting Zhang Chao Yu Chao Yu Chao Yu Chao Yu Tao Wang Tao Wang Tao Wang Tao Wang Wei Zhou Wei Zhou Wei Zhou Wei Zhou Huihui Bao Huihui Bao Huihui Bao Huihui Bao Xiaoshu Cheng Xiaoshu Cheng Xiaoshu Cheng Xiaoshu Cheng |
| author_sort | Liting Zhang |
| collection | DOAJ |
| description | ImportanceLittle is known about the relationship between the metabolic score for insulin resistance (METS-IR) and the prognosis of hypertensive patients in China.ObjectiveTo investigate the association between the novel non–insulin‐based METS-IR index and the cardiovascular composite endpoints and all-cause mortality in Chinese hypertensive participants.Design, setting, and participantsThis cohort study used data from the China H-Type Hypertension Project, a long-term prospective cohort consisting of 14234 hypertensive patients in southern China, with a baseline from March to August 2018. The median follow-up period for participants was 3.94 years, as of 2022. The data analysis period is from July 2023 to September 2023.ExposuresMETS-IR index of participants in the Chinese H-type hypertension project. The calculation formula for METS-IR is (Ln (2 × FPG) +TG) × BMI/Ln (HDL-C).Main outcomes and measuresCardiovascular events and cardiovascular, all-cause mortality were identified by linking the cohort database with the health care system through October, 2023.ResultsA total of 14220 participants were included in this study. The prevalence rates of cardiovascular disease (CVD), cardiovascular death, and all-cause death were 2.59% (369/14220), 2.79% (397/14220), and 5.66% (805/14220), respectively. After adjusting for confounding factors in the multivariate logistic regression analysis models, the METS-IR index was significantly positively correlated with CVD, and cardiovascular, all-cause mortality, whether as a categorical or continuous variable. Layered analysis showed that the METS-IR index of hypertensive participants in different subgroups was positively correlated with the endpoint event.Conclusions and relevanceThis large, prospective cohort study demonstrated that the METS-IR index, a new IR evaluation index, were independently associated with a higher risk of the cardiovascular composite endpoint and all-cause mortality among Chinese hypertensive population. Importantly, our finding provides an independent indicator for evaluating the prognosis of hypertensive patients. |
| first_indexed | 2024-04-25T01:42:02Z |
| format | Article |
| id | doaj.art-51a5018a220c4d19a6b738b82910e072 |
| institution | Directory Open Access Journal |
| issn | 1664-2392 |
| language | English |
| last_indexed | 2024-04-25T01:42:02Z |
| publishDate | 2024-03-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Endocrinology |
| spelling | doaj.art-51a5018a220c4d19a6b738b82910e0722024-03-08T04:43:55ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922024-03-011410.3389/fendo.2023.13264361326436Association of the metabolic score for insulin resistance with cardiovascular diseases, cardiovascular and all-cause mortality in Chinese hypertensive populationLiting Zhang0Liting Zhang1Liting Zhang2Liting Zhang3Chao Yu4Chao Yu5Chao Yu6Chao Yu7Tao Wang8Tao Wang9Tao Wang10Tao Wang11Wei Zhou12Wei Zhou13Wei Zhou14Wei Zhou15Huihui Bao16Huihui Bao17Huihui Bao18Huihui Bao19Xiaoshu Cheng20Xiaoshu Cheng21Xiaoshu Cheng22Xiaoshu Cheng23Department of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang of Jiangxi, ChinaCenter for Prevention and Treatment of Cardiovascular Diseases, the Second Affiliated Hospital of Nanchang University, Nanchang of Jiangxi, ChinaJiangxi Provincial Cardiovascular Disease Clinical Medical Research Center, Nanchang of Jiangxi, ChinaJiangxi Sub-center of National Clinical Research Center for Cardiovascular Diseases, Nanchang of Jiangxi, ChinaDepartment of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang of Jiangxi, ChinaCenter for Prevention and Treatment of Cardiovascular Diseases, the Second Affiliated Hospital of Nanchang University, Nanchang of Jiangxi, ChinaJiangxi Provincial Cardiovascular Disease Clinical Medical Research Center, Nanchang of Jiangxi, ChinaJiangxi Sub-center of National Clinical Research Center for Cardiovascular Diseases, Nanchang of Jiangxi, ChinaDepartment of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang of Jiangxi, ChinaCenter for Prevention and Treatment of Cardiovascular Diseases, the Second Affiliated Hospital of Nanchang University, Nanchang of Jiangxi, ChinaJiangxi Provincial Cardiovascular Disease Clinical Medical Research Center, Nanchang of Jiangxi, ChinaJiangxi Sub-center of National Clinical Research Center for Cardiovascular Diseases, Nanchang of Jiangxi, ChinaDepartment of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang of Jiangxi, ChinaCenter for Prevention and Treatment of Cardiovascular Diseases, the Second Affiliated Hospital of Nanchang University, Nanchang of Jiangxi, ChinaJiangxi Provincial Cardiovascular Disease Clinical Medical Research Center, Nanchang of Jiangxi, ChinaJiangxi Sub-center of National Clinical Research Center for Cardiovascular Diseases, Nanchang of Jiangxi, ChinaDepartment of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang of Jiangxi, ChinaCenter for Prevention and Treatment of Cardiovascular Diseases, the Second Affiliated Hospital of Nanchang University, Nanchang of Jiangxi, ChinaJiangxi Provincial Cardiovascular Disease Clinical Medical Research Center, Nanchang of Jiangxi, ChinaJiangxi Sub-center of National Clinical Research Center for Cardiovascular Diseases, Nanchang of Jiangxi, ChinaDepartment of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang of Jiangxi, ChinaCenter for Prevention and Treatment of Cardiovascular Diseases, the Second Affiliated Hospital of Nanchang University, Nanchang of Jiangxi, ChinaJiangxi Provincial Cardiovascular Disease Clinical Medical Research Center, Nanchang of Jiangxi, ChinaJiangxi Sub-center of National Clinical Research Center for Cardiovascular Diseases, Nanchang of Jiangxi, ChinaImportanceLittle is known about the relationship between the metabolic score for insulin resistance (METS-IR) and the prognosis of hypertensive patients in China.ObjectiveTo investigate the association between the novel non–insulin‐based METS-IR index and the cardiovascular composite endpoints and all-cause mortality in Chinese hypertensive participants.Design, setting, and participantsThis cohort study used data from the China H-Type Hypertension Project, a long-term prospective cohort consisting of 14234 hypertensive patients in southern China, with a baseline from March to August 2018. The median follow-up period for participants was 3.94 years, as of 2022. The data analysis period is from July 2023 to September 2023.ExposuresMETS-IR index of participants in the Chinese H-type hypertension project. The calculation formula for METS-IR is (Ln (2 × FPG) +TG) × BMI/Ln (HDL-C).Main outcomes and measuresCardiovascular events and cardiovascular, all-cause mortality were identified by linking the cohort database with the health care system through October, 2023.ResultsA total of 14220 participants were included in this study. The prevalence rates of cardiovascular disease (CVD), cardiovascular death, and all-cause death were 2.59% (369/14220), 2.79% (397/14220), and 5.66% (805/14220), respectively. After adjusting for confounding factors in the multivariate logistic regression analysis models, the METS-IR index was significantly positively correlated with CVD, and cardiovascular, all-cause mortality, whether as a categorical or continuous variable. Layered analysis showed that the METS-IR index of hypertensive participants in different subgroups was positively correlated with the endpoint event.Conclusions and relevanceThis large, prospective cohort study demonstrated that the METS-IR index, a new IR evaluation index, were independently associated with a higher risk of the cardiovascular composite endpoint and all-cause mortality among Chinese hypertensive population. Importantly, our finding provides an independent indicator for evaluating the prognosis of hypertensive patients.https://www.frontiersin.org/articles/10.3389/fendo.2023.1326436/fullinsulin resistanceMETS-IRcardiovascular eventscardiac deathall-cause mortalityshock |
| spellingShingle | Liting Zhang Liting Zhang Liting Zhang Liting Zhang Chao Yu Chao Yu Chao Yu Chao Yu Tao Wang Tao Wang Tao Wang Tao Wang Wei Zhou Wei Zhou Wei Zhou Wei Zhou Huihui Bao Huihui Bao Huihui Bao Huihui Bao Xiaoshu Cheng Xiaoshu Cheng Xiaoshu Cheng Xiaoshu Cheng Association of the metabolic score for insulin resistance with cardiovascular diseases, cardiovascular and all-cause mortality in Chinese hypertensive population Frontiers in Endocrinology insulin resistance METS-IR cardiovascular events cardiac death all-cause mortality shock |
| title | Association of the metabolic score for insulin resistance with cardiovascular diseases, cardiovascular and all-cause mortality in Chinese hypertensive population |
| title_full | Association of the metabolic score for insulin resistance with cardiovascular diseases, cardiovascular and all-cause mortality in Chinese hypertensive population |
| title_fullStr | Association of the metabolic score for insulin resistance with cardiovascular diseases, cardiovascular and all-cause mortality in Chinese hypertensive population |
| title_full_unstemmed | Association of the metabolic score for insulin resistance with cardiovascular diseases, cardiovascular and all-cause mortality in Chinese hypertensive population |
| title_short | Association of the metabolic score for insulin resistance with cardiovascular diseases, cardiovascular and all-cause mortality in Chinese hypertensive population |
| title_sort | association of the metabolic score for insulin resistance with cardiovascular diseases cardiovascular and all cause mortality in chinese hypertensive population |
| topic | insulin resistance METS-IR cardiovascular events cardiac death all-cause mortality shock |
| url | https://www.frontiersin.org/articles/10.3389/fendo.2023.1326436/full |
| work_keys_str_mv | AT litingzhang associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT litingzhang associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT litingzhang associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT litingzhang associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT chaoyu associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT chaoyu associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT chaoyu associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT chaoyu associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT taowang associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT taowang associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT taowang associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT taowang associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT weizhou associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT weizhou associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT weizhou associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT weizhou associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT huihuibao associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT huihuibao associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT huihuibao associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT huihuibao associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT xiaoshucheng associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT xiaoshucheng associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT xiaoshucheng associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation AT xiaoshucheng associationofthemetabolicscoreforinsulinresistancewithcardiovasculardiseasescardiovascularandallcausemortalityinchinesehypertensivepopulation |